Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
11.85
-0.05 (-0.42%)
Jan 22, 2026, 12:57 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 1.07 billion as of January 21, 2026. Its market cap has decreased by -23.72% in one year.
Market Cap
1.07B
Enterprise Value
1.21B
Revenue
371.86M
Ranking
n/a
PE Ratio
46.52
Stock Price
11.85
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 1.07B, a decrease of -73.86%. That is a compound annual growth rate of -9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.07B | 6.73% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |